The Role of GDF-15 in Organ Injury
The Role of GDF-15 in Organ Injury
批准号:
6941664
负责人:
LEONIDAS G. KONIARIS
金额:
$12.04万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2006-08-31
关键词:
bile ductsbiological signal transductionblood chemistrycell proliferationchemokinecytokinegene expressiongenetically modified animalsinflammationinjurykidneylaboratory mouseliverliver cellslung injurylymphocytemacrophagemessenger RNAorganprotein structure functionshocktissue /cell culturetransforming growth factors
中文摘要
描述(由申请人提供):本提案旨在为
医学博士,医学博士,科学发展观
罗切斯特大学医学院的外科医生。候选人,一个
胃肠和创伤外科医生,有四年以上的基础科学知识
细胞因子的功能和信号与生长的研究培训
因素,为一项有指导的研究计划寻求资金,以审查
新的分泌因子GDF-15在休克和器官损伤中的作用休克与器官
损伤是常见的细胞因子依赖的病理生理过程,导致
几乎所有严重疾病州的发病率和死亡率。我们
还有一些人克隆了新的转化生长因子-B(TGF-B)超家族
成员gdf-15及其人类同源基因gdf-L 4.gdf-15的高效表达
诱导小鼠肝、胆管、肾、肺损伤及休克模型。
同样,GDF-14在急性和慢性人类肝病中高度表达。
GDF-15基因缺失小鼠巨噬细胞高表达炎性细胞因子和
未刺激状态和佛波醇治疗后的趋化因子
埃斯特。另有报道称,GDF-14可以通过转化生长因子-β受体和
发挥转化生长因子-β样抗增殖作用。总而言之,这些数据表明
GDF-14/15是休克和器官损伤的早期信号或介体,
GDF-14/15可能通过调节细胞因子来限制炎症反应
巨噬细胞产生GDF14/15可能调节实质细胞
组织损伤后的增殖。这项提案旨在确定
GDF-15的功能,通过描述其表达模式,通过评估
GDF-15基因缺失小鼠对器官损伤和休克的反应
重组GDF-15体外对巨噬细胞和实质细胞的影响
在体内过表达的小鼠体内。候选人将由
外科主席、医学博士、免疫学I教授詹姆斯·V·西尔兹曼。
Nickolas Crispe博士,他将在以下领域提供专业知识和培训
小鼠外科手术和休克及巨噬细胞方法学。这个
本次辅导性研究培训的完成是否会进一步推动候选人S的目标?
将基础科学发现应用于外科手术的治疗
疾病作为一个独立的调查者。
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks funding for the
scientific development of Leonidas Koniaris, M.D., an Assistant Professor of
Surgery at the University of Rochester School of Medicine. The candidate, a
gastrointestinal and trauma surgeon with over four years of basic science
research training in the function and signaling of cytokines and growth
factors, seeks funding for a mentored research program to examine the role of a
novel secreted factor, GDF-15, in shock and organ injury. Shock and organ
injury are common cytokine-dependent pathophysiologic processes that lead to
the morbidity and mortality seen in virtually all serious disease states. We
and others have cloned the new Transforming Growth Factor-B (TGF-B) superfamily
members GDF-15, and its human homologue GDF-l 4. GDF- 15 expression is potently
induced in mouse models of liver, bile duct, kidney and lung injury and shock.
Likewise, GDF-14 is highly expressed in acute and chronic human liver disease.
Macrophages from GDF-15 null mice hyper-express inflammatory cytokines and
chemokines both in the unstimuiated state and after treatment with phorbol
ester. Others report that GDF-14 can signal through the TGF-B receptor and
exert TGF-B-like anti-proliferative effects. Taken together these data suggest
that GDF- 14/15 is an early signal or mediator of shock and organ injury, that
GDF- 14/15 may limit the inflammatory response by regulating cytokine
production by macrophages, and that GDF 14/15 may regulate parenchymal cell
proliferation after tissue injury. This proposal seeks to determine the
function of GDF- 15 by describing its expression pattern, by evaluating the
response of GDF-15 null mice to organ injury and shock, and by examining the
effect of recombinant GDF-15 in vitro on macrophages and parenchymal cells and
in vivo in over-expressing mice. The candidate will be sponsored by the
Chairman of Surgery, James V. Silzmann, M.D., and Professor of Immunology I.
Nickolas Crispe, Ph.D., who will provide expertise and training in the areas of
murine surgery and shock and macrophage methodology respectively. The
completion of this mentored research training will further the candidate?s goal
of applying bench-derived scientific discovery to the treatment of surgical
disease as an independent investigator.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1097/01.shk.0000163393.55350.70
发表时间:
2005-06
期刊:
Shock
影响因子:
3.1
作者:
[T. Zimmers;Xiaoling Jin;E. Hsiao;S. McGrath;A. Esquela;L. Koniaris]
通讯作者:
T. Zimmers;Xiaoling Jin;E. Hsiao;S. McGrath;A. Esquela;L. Koniaris
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10634587
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10172473
-
项目类别:
-
资助金额:$26.66万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10441216
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10349585
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10393304
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10875228
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10171874
-
项目类别:
-
资助金额:$41.42万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10569038
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8830782
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8697048
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8345698
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8535753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Increasing Functional Liver Mass in Health and Disease
-
批准号:6820902
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Increasing Functional Liver Mass in Health and Disease
-
批准号:6944355
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6818985
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6360371
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6526212
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6800759
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
海外基金